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Group B streptococcal (GBS) tricuspid infective endocarditis is a very rare clinical entity. It affects intravenous drug
users, pregnant, postpartum women, and the elderly. We report the case of a 68-year-old patient without known
predisposing factors who presented a GBS tricuspid endocarditis treated by penicillin and aminoglycosides with no
response. The patient was operated with a good evolution. Our case is the 25th reported in the literature. GBS disease is
increasing in the elderly and is mainly associated to comorbid conditions. Tricuspid infective endocarditis with Group
B streptococcus predominantly presents as a persistent fever with respiratory symptoms due to pulmonary embolism.
Therefore, it requires a medicosurgical treatment and close follow-up.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Right-sided infective endocarditis (RSIE) is arare clinical entity that occurs predominantly
in intravenous drug users and involves mainly the
tricuspid valve [1]. Pathogenesis, clinical features,
and prognosis of RSIE occurring in nondrug users
are not well known [2]. In fact, there are only a few
studies on RSIE in nondrug users without humanimmunodeficiency virus infection. Staphylococcus
aureus is the most common microbiological
pathogen. Other causes of RSIE include
coagulase-negative staphylococci and streptococci
[3,4]. Group B Streptococcus (Streptococcus
agalactiae) is a b-hemolytic Gram-positive bac-
terium [5]. This pathogen is a member of the
genitourinary female tract and gastrointestinal
normal flora in some humans [5]. S. agalactiae is
one of the major causes of neonatal bacterialeCCBY-
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coccal disease (GBS), once rare in adults, is actu-
ally in perpetual increase, especially in the
elderly [7]. However, GBS infective endocarditis
remains a rare clinical entity (3% of GBS invasive
infections) [7]. It mainly affects the left-sided heart
valves and rarely the tricuspid valve [8]. In this
paper we report the case of an elderly patient
without known comorbidities who presented with
tricuspid endocarditis due to S. agalactiae. The
pathophysiology, clinical features, and therapeutic
options are reviewed.Case report
A 68-year-old man was admitted with prolonged
fever, arthralgia, headache, and asthenia of 3
weeks’ duration. The patient had no history of car-
diovascular disease or illicit drugs abuse. There
was no notion of recent hospitalization or intra-
venous catheter placement. On admission, the
patient was pale with dyspnea at rest. On exami-
nation, his temperature, blood pressure, pulse,
respiratory rate, and oxygen saturation while
breathing room air were, respectively: 39.2 C;
115/70 mmHg; 96 beats/min; 24 breaths/min; and
96%. Auscultation of lung fields was normal. Car-
diac auscultation revealed a systolic murmur at
the left lower sternal border increasing with inspi-
ration. Physical examination revealed jugular
veins distension with a hepatojugular reflux and
a mild painful hepatomegaly. The electrocardio-
gram showed a sinus tachycardia. Chest X-ray
revealed a mild cardiomegaly. Laboratory tests
revealed leukocytosis of 13.2  109, anemia with
hemoglobin of 9.3 g/dL, erythrocyte sedimenta-
tion rate of 90 mm/h, and C-reactive protein of
260 mg/L. On transthoracic and transesophagealFigure 1. Transesophageal echocardiography revealing a large, mobile and
anterior tricuspid valve with severe regurgitation.echocardiography, there was a large, mobile,
and pedunculated vegetation measuring
15 mm  10 mm attached to the anterior tricuspid
valve with severe regurgitation (Fig. 1) and severe
pulmonary hypertension (systolic pulmonary
arterial pressure = 55 mmHg). The right ventricle
had normal size and function (tricuspid annular
plane systolic excursion = 25 mm; S
wave = 13 cm/s). The left ventricle and aortic and
mitral valves were normal. The diagnosis of
right-sided infective endocarditis was made.
Treatment with vancomycin and gentamycin was
started after several blood culture series and urine
analysis. There were no organisms in the urine.
S. agalactiae was isolated in three blood cultures.
Since this bacterium was sensitive to penicillin
and aminoglycosides, vancomycin was stopped
and changed to penicillin. Abdominal and cere-
bral CT scans were normal. Human immunodefi-
ciency virus and tumor markers were negative
and digestive exploration including colonoscopy
was normal. After 2 weeks with appropriate
antibiotic treatment, the patient complained of
fever and dyspnea. A ventilation–perfusion lung
scan showed matched ventilation and perfusion
defect at the lingual secondary to septic
pulmonary embolism. A control transesophageal
echocardiography revealed a further increase in
the vegetation of the tricuspid valve and there
was no inflammatory resolution: C-reactive pro-
tein rate remained 180 mg/L after an initial
decrease. Medical treatment was changed again
to daily vancomycin, gentamycin, and rifampicin
and the patient underwent surgery. Large vegeta-
tion was attached to the tricuspid valve (Fig. 2).
The surgery had consisted at a resection of the
vegetation, tricuspid valve repair and annulo-
plasty with a Carpentier–Edwards ring No. 28.pedunculated vegetation measuring 15 mm  10 mm attached to the
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Figure 2. Surgery revealed large vegetation attached to the anterior
tricuspid valve.
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transthoracic echocardiography revealed a mild
tricuspid regurgitation without residual vegeta-
tion (Fig. 3). Bacteriological analysis of the
vegetation revealed the presence of neutrophils
and organisms. Antibiotics were continued until
6 weeks, and the patient was discharged after total
clinical and biological recovery. The patient was
regularly followed-up. Six months later he was
doing well with stable vital signs and no dyspnea
or fever. The transthoracic echocardiogram at
follow-up demonstrated a moderate tricuspid
valve regurgitation.Discussion
RSIE is rarer than left-sided involvement,
accounting for around 5–10% of all cases of infec-Figure 3. Control transthoracic echocardiography revealed: (A) tricuspid ri
regurgitation after annuloplasty.tive endocarditis [1]. It occurs predominantly in
intravenous drug users and where intravenous
devices (e.g., pacemakers, central venous
catheters) are used. S. aureus is the most common
microbiological organism. Other pathogenic
bacteria of RSIE are streptococci [3,4].
S. agalactiae is a b-hemolytic Gram-positive bac-
terium [5]. It colonizes the female genitourinary
tract, throat, and rectum of some humans [5]. It
was first identified as the major cause of bovine
endocarditis [9]. Later, it was described as a
human pathogen that principally caused sepsis
and meningitis in neonates, and could lead to
death or long-term sequelae [6]. The susceptibility
of infants and women who are pregnant and after
obstetrical intervention to GBS disease depends
on the level of capsular-type-specific antibodies
in maternal serum [10]. Recently, the incidence
of the GBS invasive infections in adults who are
not pregnant is increasing [7]. In fact, a two to
four-fold increase in the incidence of invasive
GBS disease in adults has been reported during
the past two decades; most infections are unre-
lated to pregnancy and occur in adults aged
P65 years [7,11]. The pathogenesis of GBS inva-
sive disease in the elderly is multifactorial and is
still poorly understood. It has been established
that complement receptors present in neutrophils
play a specific role in the susceptibility to the GBS
disease. The chronic underlying diseases such as
diabetes mellitus, malignancy, cardiac, gastroin-
testinal diseases, and neurological impairment
frequent in elderly adults compromise the mecha-
nisms of host–defense and alter the function of the
neutrophils [10]. In addition, the reduced physical
capacity, altered integrity of anatomical barriers in
the elderly, and intrinsic virulence of S. agalactiaeng without residual vegetation; and (B) persistence of a mild tricuspid
Table 1. Different cases of group B Streptococcus tricuspid infective endocarditis reported in the literature.
Case
No./
Refs.
Age
(y)
Sex IV
drug
abuse
Underlying
disease/
circumstance
Clinical
presentation
Pulmonary
embolism
Antibiotic Surgery Evolution
1 [19] 24 F No Cesarean Acute Yes Penicillin Yes Recovery
2 [20] 19 F Yes Abortion Subacute Yes Penicillin + gentamicin Yes Recovery
3 [8] 35 M Yes None Acute Yes Penicillin No Recovery
4 [21] 65 F No Alcoholism/
breast cancer
— — Penicillin Yes Recovery
5 [18] 32 F Yes None Subacute Yes Penicillin + gentamicin No Recovery
6 [18] 56 M No Diabetes Acute Yes Ampicillin No Death
7 [18] 54 M No Diabetes,
alcoholism
Acute Yes Penicillin + tobramycin No Recovery
8 [22] 22 F Yes None Acute Yes Penicillin + gentamicin No Death
9 [22] 13 F No None Acute No Penicillin No Recovery
10 [22] 32 F Yes None Acute Yes Penicillin No Recovery
11 [23] 24 F No Abortion Acute Yes Penicillin + gentamicin No Recovery
12 [24] 30 F No Abortion Subacute Yes Vancomycin Yes Recovery
13 [14] — F — — — — Yes — —
14 [13] 33 F No Abortion Acute Yes Penicillin + gentamicin Yes Recovery
15 [5] 18 F No Abortion Acute Yes Yes Yes Recovery
16 [25] 25 M Yes None Acute No Penicillin + gentamicin No Recovery
17 [25] 22 M Yes None Acute No Penicillin No Recovery
18 [5] 53 F No Alcoholism Acute Yes Penicillin + tobramycin No Death
19 [26] 19 F None Acute Yes Yes No Death
20 [27] 22 F No Abortion Acute Yes Penicillin + gentamicin No Recovery
21 [28] 27 F No None Acute Yes Penicillin + gentamicin No Recovery
22 [15] — F No Papanicolaou
smear
— — Yes Yes Recovery
23 [16] 36 F No Postpartum Acute No Ceftriaxone
+ gentamicin
+ metronidazole
No Death
24 [17] 30 F No Postpartum Acute Yes Ceftriaxone
+ gentamicin
+ vancomycin
Yes Recovery
25a 68 M No None Acute Yes Vancomycin
+ rifampicin
+ gentamicin
Yes Recovery
Ref = reference.
a Case reported in this article.
C
A
SE R
EPO
RT
122 ABID ET AL
STREPTOCOCCUS AGALACTIAE TRICUSPID ENDOCARDITIS
J Saudi Heart Assoc
2016;28:119–123due to specific capsular polysaccharides of the
GBS may contribute to the occurrence of GBS
invasive infections in the elderly [12]. Despite
the recent increase in GBS invasive disease,
infective endocarditis remains uncommon (3% of
clinical manifestations of invasive GBS infections)
[7]. S. agalactiae-infective endocarditis is a very
aggres- sive clinical entity characterized by acute
onset, large vegetations, and severe valve mutila-
tions and reaches old patients with chronic under-
lying diseases, mostly rheumatic heart disease [5].
The mitral and aortic valves are the most involved
(77% of all cases) [5].
S. agalactiae RSIE is very rare and involves either
drug users, pregnant women, and elderly adults
[13]. Only 24 cases of GBS infective endocarditis
involving the tricuspid valve have been reported
in the literature [14–17]; our case is the 25th to
be described (Table 1) [5,8,13–28].Only seven patients were intravenous drug
abusers and four had underlying chronic diseases.
Most patients (19 of 24) were female and infective
endocarditis occurred after obstetrical interven-
tion in 10 of them [16,17]. The clinical presentation
was severe with acute onset, large vegetation, and
tricuspid valve mutilation in most patients (88%).
Seventeen patients presented pulmonary embo-
lism. The antibiotic of choice was an association
of penicillin and aminoglycoside [13]. Surgical
treatment were indicated in seven cases and con-
sisted in valve excision and replacement with a
bioprothesis or tricuspid annuloplasty according
to valve anatomy. All patients who underwent
surgery had a good evolution [15–17]. Five
patients who received only medical treatment
died (29.4%) [16]. Our patient was the oldest
described in the literature. He had no debilitating
disease and did not consume any illicit drugs. In
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STREPTOCOCCUS AGALACTIAE TRICUSPID ENDOCARDITISour patient, surgical treatment was indicated
because of ongoing infection, increasing size of
tricuspid vegetation, occurrence of pulmonary
embolism, and right heart failure despite adapted
antibiotics. The indication of surgery in GBS RSIE
is less established than in left-sided endocarditis
[8,13]. The mortality in GBS tricuspid valve
endocarditis is also lower than the left-sided
endocarditis in which mortality rate can reach
50–100% if medical treatment only [5,8,18]. These
data suggest that a combined medical-surgical
treatment with early surgery could be the strategy
of choice when S. agalactiae is responsible of the
infection. Because of the frequent association with
predisposing conditions and comorbidities, a close
follow-up of our patient is necessary in order to
detect on time a possible underlying malignancy
that may be revealed by GBS tricuspid infective
endocarditis.Conclusion
GBS infective endocarditis is an aggressive clin-
ical entity. Tricuspid valve involvement is rare and
frequently occurs in postpartum and older patients
with debilitating diseases. Because of the high
probability of valve mutilation, severe complica-
tions, and poor prognosis, an appropriate medi-
cal–surgical approach seems to be the strategy of
choice in this infection.
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